Proton beam therapy for a patient with a giant thymic carcinoid tumor and severe superior vena cava syndrome

Rare Tumors

Volumn 6, Issue 2, 2014, Pages 36-38

  Sugawara, Kaori ^a   Mizumoto, Masashi ^a   Numajiri, Haruko ^a   Ohno, Toshiki ^a   Ohnishi, Kayoko ^a   Ishikawa, Hitoshi ^a   Okumura, Toshiyuki ^a   Sakurai, Hideyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Mediastinal tumor; Proton beam therapy; Radiation; Superior vena cava syndrome; Thymic carcinoid tumor

Indexed keywords

CISPLATIN; ETOPOSIDE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; IRINOTECAN;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CARCINOID; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DYSPNEA; FACE EDEMA; FEMALE; GIANT THYMIC CARCINOID TUMOR; HEART FAILURE; HUMAN; PLEURA EFFUSION; PROTON THERAPY; RADIATION DOSE; SUPERIOR CAVA VEIN SYNDROME; TREATMENT PLANNING; TUMOR GROWTH; TUMOR VOLUME;

EID: 84900447845     PISSN: 20363605     EISSN: 20363613     Source Type: Journal    
DOI: 10.4081/rt.2014.5177     Document Type: Article

References (19)

1. Rosai J, Higa E. Medeastinal endocrine neoplasm, of probable thymic origin, related to carcinoid tumor. Cancer 1972;29: 1061-74.
2. Moran CA, Suster S. Spindle-cell neuroendocrine carcinoma of thymus: a clinicopathologic and immunohistochemical study of seven cases. Mod Pathol 1999;12:587-91.
3. Tiffet O, Nicholson AG, Ladas G, et al. A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus. Chest 2003;124:141-6.
4. de Montpréville VT, Macchiarini P, Dulmet E. Thymic neuroendocrine carcinoma (carcinoid): a clinicopathologic study of fourteen cases. J Thorac Cardiovasc Surg 1996;111:134-41.
5. Filosso PL, Actis Dato GM, Ruffini E, et al. Multidisciplinary treatment of advanced thymic neuroendocrine carcinoma (carcinoid): Report of a successful case and review of the literature. J Thorac Cardiovasc Surg 2004;127:1215-9.
6. Fukai I, Masaoka A, Fujii Y, et al. Thymic neuroendocrine tumor (thymic carcinoid): a clinicopathologic study in 15 patients. Ann Thorac Surg 1999;67:208-11.
7. Valeriani M, Agolli L, Falco T, et al. A case report of metastatic atypical thymic carcinoid with ectopic ACTH production: locoregional control after adaptive radiation treatment. Tumori 2012;98:e172-5.
8. Oshiro Y, Mizumoto M, Okumura T, et al. Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer. J Thorac Oncol 2012;7:370-5.
9. Mizumoto M, Sugahara S, Okumura T, et al. Hyperfractionated concomitant boost proton beam therapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys 2011;81:e601-6.
10. Mizumoto M, Okumura T, Hashimoto T, et al. Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols. Int J Radiat Oncol Biol Phys 2011;81:1039-45.
11. Mizumoto M, Tsuboi K, Igaki H, et al. Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2010; 77: 98-105.
12. Ohara K, Okumura T, Akisada M, et al. Irradiation synchronized with respiration gate. Int J Radiat Oncol Biol Phys 1989;17:853-7.
13. Tsunashima Y, Sakae T, Shioyama Y, et al. Correlation between the respiratory waveform measured using a respiratory sensor and 3D tumor motion in gated radiotherapy. Int J Radiat Oncol Biol Phys 2004;60:951-8.
14. Tsujii H, Tsuji H, Inada T, et al. Clinical results of fractionated proton therapy. Int J Radiat Oncol Biol Phys 1993;25:49-60.
15. Oshiro Y, Okumura T, Mizumoto M, et al. Proton beam therapy for unresectable hepatoblastoma in children: survival in one case. Acta Oncol 2013;52:600-3.
16. Mizumoto M, Hashii H, Senarita M, et al. Proton beam therapy for malignancy in Bloom syndrome. Strahlenther Onkol 2013;189:335-8.
17. Oshiro Y, Mizumoto M, Okumura T, et al. Clinical results of proton beam therapy for advanced neuroblastoma. Radiat Oncol 2013;8:142.
18. Mizumoto M, Okumura T, Ishikawa E, et al. Reirradiation for recurrent malignant brain tumor with radiotherapy or proton beam therapy. Strahlenther Onkol 2013 [in press].
19. Mizumoto M, Sugahara S, Nakayama H, et al. Clinical results of proton-beam therapy for locoregionally advanced esophageal cancer. Strahlenther Onkol 2010;186:482-8.